Clinical Trials
Mixed Oxford/Pfizer vaccine schedules generate robust immune response against COVID-19, finds Oxford-led study
Alternating doses of the Oxford-AstraZeneca and Pfizer-BioNTech vaccines generate robust immune responses against COVID-19, according to researchers running the University of Oxford-led Com-COV study.
In...
News
Pharma logistics specialist Medexi to open Pharma Center at Brussels Airport
Brussels Airport continues to invest in its logistics zone Brucargo, where it took delivery of a new building accommodating 4,000m² of warehousing and office...
Press Releases
Moderna Announces Emergency Use Authorization for its COVID-19 Vaccine Granted by Government of India
Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, announced that the government of India has issued a registration certificate and...
News
RedHill Biopharmas opaganib shows activity against Covid-19 variants
RedHill Biopharma has reported initial findings from a preclinical study, which revealed that its drug candidate, opaganib (Yeliva, ABC294640), could block Covid-19 variants of...
News
Lonza Invests CHF 20 million to Expand API Development and Manufacturing Facility in Nansha, China
Lonza announced new investments in GMP laboratories and mid-scale manufacturing assets at its API manufacturing center in Nansha, China. The investments, totaling over CHF...
Press Releases
Roche’s Actemra/RoActemra receives U.S. FDA EUA for the treatment of COVID-19 in hospitalised adults and children
Roche announced that the U.S. FDA has issued an EUA for intravenous Actemra/RoActemra® (tocilizumab) for the treatment of COVID-19 in hospitalised adults and paediatric...
Clinical Trials
CluePoints Launch Post-COVID Trial Assurance Solution
CluePoints, the premier provider of Risk-Based Quality Management Solutions for clinical trials, has launched a new Post-COVID Trial Assurance Solution as part of its mission...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read